A phase IIa, randomized, open-label study evaluating the safety and efficacy of CreaVax-RA combined with traditional disease modifying anti-rheumatic drugs (DMARDs) therapy in patients with moderate to severe active rheumatoid arthritis despite DMARDs therapy
A phase I, open label, dose ranging study to evaluate the safety and tolerance of CreaVax-RA in active rheumatoid arthritis patients with usual DMARDs
100 项与 CreaVax-RA 相关的临床结果
100 项与 CreaVax-RA 相关的转化医学
100 项与 CreaVax-RA 相关的专利(医药)
100 项与 CreaVax-RA 相关的药物交易